Prosecution Insights
Last updated: October 01, 2026
Application No. 18/347,818

Stretchable Member Transcatheter Valve

Non-Final OA §102
Filed
Jul 06, 2023
Priority
Jul 26, 2022 — provisional 63/369,458
Examiner
SNOW, BRUCE EDWARD
Art Unit
3774
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Abbott Laboratories
OA Round
1 (Non-Final)
75%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
83%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allowance Rate
771 granted / 1022 resolved
+5.4% vs TC avg
Moderate +8% lift
Without
With
+8.0%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
43 currently pending
Career history
1050
Total Applications
across all art units

Statute-Specific Performance

§101
2.6%
-37.4% vs TC avg
§103
32.3%
-7.7% vs TC avg
§102
25.8%
-14.2% vs TC avg
§112
28.2%
-11.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1022 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Species 1a (455, figures 3A-3B) in the reply filed on 7/14/2026 is acknowledged. Claims 8-12 have been withdrawn directed to non-elected species 1b. Claims 16-20 have been withdrawn directed to non-elected species 1d. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-2, 5-7 and 15 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Haarer et al (11,090,153). Referring to at least figures 8A-8D, Haarer et al et al teaches a prosthetic heart valve system, comprising: PNG media_image1.png 398 716 media_image1.png Greyscale PNG media_image2.png 397 716 media_image2.png Greyscale an outer stent 1100; an inner stent 1200 coupled to the outer stent, the inner stent supporting a valve assembly including a cuff (see at least 11:60-12:3, not shown) and a plurality of leaflets 1210; and at least one linking member 1700 coupling the outer stent to the inner stent, the at least one linking member being transitionable between a collapsed condition and a relaxed condition, the inner stent 820 being axially spaced away from the outer stent when the at least one linking member is in the collapsed condition (see at least figures 8A and 8C), and the inner stent being at least partially nested within the outer stent when the at least one linking member is in the relaxed condition (see at least figures 8B and 5E). Claim 2, wherein at least one linking member includes multiple linking members 1700. Claim 5, “wherein each of the at least one linking member is C-shaped in the relaxed condition” is believed to be shown in applicant’s figure 3D (455a). Referring to said figure, the C-shape appears to be portion of a continuous scallop shape or wave. The examiner depicts a “C-shape” as follow: PNG media_image3.png 327 399 media_image3.png Greyscale Claim 6, wherein each of the at least one linking member extends past a remainder of the outer stent in the collapsed condition; see at least figures 8A and 8C. Claim 7, it is the examiner’s position that figures 8A and 8C shown the inner stent is fully nested within the outer stent when the at least one linking member is in the relaxed condition. Additionally, see the teaching in figure 6, wherein the inner stent 1200 is fully nested in the outer stent 1100. Claim 15, at least figures 8A and 8C teach the inner stent has no axial overlap with the outer stent when the at least one linking member is in the collapsed condition. Allowable Subject Matter Claims 3-4 and 13-14 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is an examiner’s statement of reasons for allowance: The closes prior art of record is Haarer et al (11,090,153) as explained above. Haarer et al falls short of teaching the combination of claims 1-2 and 3, wherein the inner stent includes a plurality of commissure nodes, each of the plurality of commissure nodes being coupled to a corresponding one of the multiple linking members. Additionally, Haarer et al fails to teach the combination of claim 1 and claim 13, wherein the inner stent includes a plurality of commissure nodes, each of the plurality of commissure nodes being coupled to two linking members. The examiner further notes Burkart et al (2020/0276014), figure 7D3, teaching a outer frame 1100 and an inner frame 1200 coupled by at least one linking member 1400. PNG media_image4.png 744 508 media_image4.png Greyscale The inner stent comprising peaks and valley wherein some peaks are connected to two linking members 1400. Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.” Any inquiry concerning this communication or earlier communications from the examiner should be directed to BRUCE EDWARD SNOW whose telephone number is (571)272-4759. The examiner can normally be reached 7:30 am - 5:00 pm Monday through Thursday. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Melanie Tyson can be reached at 5712729062. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BRUCE E SNOW/Primary Examiner, Art Unit 3774
Read full office action

Prosecution Timeline

Jul 06, 2023
Application Filed
Aug 20, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746116
Reinforced Heart Valve Leaflets
3y 3m to grant Granted Sep 29, 2026
Patent 12746118
TEXTILES FOR IMPLANTATION
3y 0m to grant Granted Sep 29, 2026
Patent 12746113
INJECTOR FOR AN INTRAOCULAR LENS
2y 10m to grant Granted Sep 29, 2026
Patent 12740853
Artificial Prosthesis and Method for Manufacturing Same
3y 11m to grant Granted Sep 22, 2026
Patent 12734050
HEIGHT ADJUSTABLE PROSTHESIS PYRAMID CONNECTOR
3y 6m to grant Granted Sep 15, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
75%
Grant Probability
83%
With Interview (+8.0%)
2y 11m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1022 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month